Retatrutide vs Tirzepatide: A Research Comparison
Two of the most studied multi-receptor agonist peptides in current metabolic research — compared as laboratory reference compounds.
Retatrutide and tirzepatide are frequently mentioned together, but they are not the same compound — they differ in their receptor pharmacology and molecular design. In laboratory research they are widely used as reference and comparator standards in studies of incretin signalling and metabolic pathways. This guide compares them purely as research compounds: their class, the receptors they engage, and the contexts in which researchers study them.
At a glance
| Tirzepatide | Retatrutide | |
|---|---|---|
| Class | Dual receptor agonist | Triple receptor agonist |
| Receptor targets | GIP + GLP-1 | GIP + GLP-1 + glucagon |
| Research context | Reference/comparator in incretin-pathway studies | Reference compound in multi-pathway metabolic studies |
| Format | Lyophilised powder, 10mg vial | Lyophilised powder, 10mg vial |
| Supplied for | In-vitro / laboratory research only | |
The core difference: receptor targets
Both peptides belong to the incretin-mimetic class — synthetic analogues designed to engage the body's incretin receptors. The key distinction is how many receptors each one targets:
- Tirzepatide is a dual agonist: it engages the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors.
- Retatrutide is a triple agonist: it engages GIP, GLP-1 and, additionally, the glucagon receptor.
That extra glucagon-receptor activity is the main reason retatrutide is of interest as a distinct research compound — it lets researchers study a broader set of metabolic-signalling pathways than a dual agonist alone. In comparative receptor-binding and signalling assays, this difference in target profile is precisely what is being examined.
Molecular design
Both are synthetic peptide analogues that incorporate structural modifications (including fatty-acid chains) associated with extended stability in research models. Their amino-acid sequences differ, which underlies their differing receptor selectivity. As reference standards, their identity and purity are what matter most in a laboratory setting — which is why independent analysis is so important (more on that below).
How researchers use them
In published in-vitro and animal-model literature, both compounds are used as comparator and reference standards when characterising incretin and multi-agonist signalling. Typical research contexts include receptor-binding studies, comparative pharmacology of single- versus multi-receptor agonists, and metabolic-pathway investigations. Retatrutide, as a newer triple agonist, is often studied alongside tirzepatide to isolate the contribution of glucagon-receptor engagement.
Storage & handling
Both are supplied as lyophilised (freeze-dried) powders. General laboratory practice is to store the lyophilised material at -20°C, protected from light and moisture, and to keep any reconstituted solution refrigerated at 2–8°C, handled according to the receiving laboratory's standard operating procedures. Always follow your own institutional protocols for reconstitution, handling and disposal.
Why third-party testing matters most
The research-peptide market is unregulated, so the single most useful quality check — for any supplier, not just us — is an independent, per-batch certificate of analysis (COA). A genuine third-party report (for example from Janoshik) shows the measured purity and a batch number you can verify yourself against the vial. If a supplier can't provide batch-specific third-party testing, treat that as a red flag. Across the Helix catalogue we publish lab reports on the product pages wherever testing has been completed.
View the research listings
Both compounds are supplied as lyophilised powder for laboratory research only, with batch references.
Retatrutide (research) Tirzepatide (research) Full catalogueFrequently asked questions
What is the main difference between retatrutide and tirzepatide?
Receptor targets. Tirzepatide is a dual GIP/GLP-1 agonist; retatrutide is a triple GIP/GLP-1/glucagon agonist. The additional glucagon-receptor activity is what distinguishes retatrutide pharmacologically.
Are they legal to buy in the UK?
Research peptides can be supplied in the UK for laboratory research only, provided they are clearly labelled as such and carry no medical claims. They are not authorised for human or veterinary use. See our research disclaimer for full detail.
How should they be stored?
As a lyophilised powder, generally at -20°C away from light and moisture; reconstituted solution refrigerated at 2–8°C, handled per laboratory SOP.
How do I verify purity?
Ask for the independent, batch-specific COA and check the purity percentage and batch number against the vial. Learn more on our catalogue, where lab reports are published per product where available.